Become a Member

Friday File: Royalties Worth a Buy?

Drugs and Fertilizer for your early Friday File

I’m headed in for carpal tunnel surgery today, so I might not be able to type my usual long missives for a little while… and that means you get your Friday File a day early. Hopefully the recovery will be quick and easy, as my doctor expects, and my fingers will be dancing on the keyboard with reckless abandon in a few days… but if you don’t hear as much from me for a week or two, that’s why.

So… what’s going on this week? Other than a market that remains obsessed with trying to figure out exactly when inflation will be really tamed, I should say — on that front nobody can know, of course, but we’re certainly all overreacting to the Fed’s guesstimates. Humans are excellent at drawing straight trend lines from whatever is happening at this minute into the future… it’s dealing with messy numbers that jump around every month that freaks us out, and that’s certainly how inflation looks these days. There’s something poetic about the world holding its breath while we wait for some economists to decide what last year’s milk prices might mean about next year’s rents. It’s nice to see bonds become a rational place to park some money again, after years when we had to ignore them, but maybe they’ll become downright exciting again if rates keep climbing.

I do have one meaningful purchase to share with you this week, the latest company to reach a “full allocation” in the Real Money Portfolio (for my philosophy about that, check out this Friday File from a few weeks ago — basically, I try to make sure I’ve invested no more than 4% of my equity money into any one company, with a few exceptions for stocks where I have an extreme level of confidence). That’s Keysight (KEYS), which I mentioned a couple weeks ago was tickling my “preferred buy” range after an earnings report that disappointed investors — they had their Investor Day this week, reassured me, and reached my buy price, so I’ve now maxed out my KEYS position. Here’s what I sent out as a Trade Note on Tuesday, in case you missed it:

Keysight (KEYS) hosted its Investor Day in NY today, and I remain impressed with their strategy and their consistently strong execution. The big press release headline from the presentation is that they raised their outlook, they ...

Irregulars Quick Take

Paid members get a quick summary of the stocks teased and our thoughts here. Join as a Stock Gumshoe Irregular today (already a member? Log in)

Sign Up for a Premium Membership

To view the rest of this article (and to have full access to the rest of our articles), sign up.
Already a member, log in.

Become a member

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
25
0
Would love your thoughts, please comment.x
()
x
Please note that this is your publicly visible biography - we recommend not including any personal information (phone, email, address, etc.) and ONLY linking to any other pages or profiles you're comfortable sharing with everyone.

Updating your Credit Card in PayPal

Your subscription is paid through your PayPal account.

To update your credit card or cancel, please log in to PayPal.com, go to your automatic payments, open the Stock Gumshoe payment, and make changes there.

More information here: Paypal — What Is an Automatic Payment and How Do I Update or Cancel One?

Exit mobile version